1,6- epi -Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease - Archive ouverte HAL
Journal Articles Journal of the American Chemical Society Year : 2022

1,6- epi -Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease

Ken Kok
  • Function : Author
Chi-Lin Kuo
Rebecca Katzy
  • Function : Author
Lindsey Lelieveld
  • Function : Author
Liang Wu
Véronique Roig-Zamboni
  • Function : Author
Architecture et fonction des macromolécules biologiques
Gijsbert van der Marel
  • Function : Author
Jeroen Codée
Gerlind Sulzenbacher
Architecture et fonction des macromolécules biologiques
Gideon Davies
Herman Overkleeft
Johannes Aerts
Marta Artola

Domains

Life Sciences [q-bio]

Gerlind Sulzenbacher  : Connect in order to contact the contributor

https://hal.science/hal-03806327

Submitted on : Friday, October 7, 2022-4:47:59 PM

Last modification on : Wednesday, October 30, 2024-6:16:17 PM

Consult the full text

Dates and versions

hal-03806327 , version 1 (07-10-2022)

Identifiers

Cite

Ken Kok, Chi-Lin Kuo, Rebecca Katzy, Lindsey Lelieveld, Liang Wu, et al.. 1,6- epi -Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease. Journal of the American Chemical Society, 2022, 144 (32), pp.14819-14827. ⟨10.1021/jacs.2c05666⟩. ⟨hal-03806327⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-AMU INRAE ANR AFMB MICA-UNITES INRAEPACA
18 View
0 Download

Altmetric

Share

More